Literature DB >> 2788073

Upper gastrointestinal bleeding in Malawian adults and value of splenomegaly in predicting source of haemorrhage.

A D Harries, J J Wirima.   

Abstract

Fibreoptic endoscopy was carried out on 100 Malawian adults consecutively admitted to the department of medicine, Kamuzu Central Hospital, Lilongwe, with acute upper gastrointestinal bleeding. The principal causes of haemorrhage were oesophageal varices (45%), duodenal ulcer (16%), gastritis/erosions (9%) and gastric ulcer (7%). 69% of 29 patients with oesophageal varices who were investigated had S. mansoni infection. A palpable spleen positively predicted oesophageal varices in 91% of cases, while no palpable spleen predicted a source of haemorrhage other than varices in 97% of cases. In Malawi oesophageal varices are the major cause of upper gastrointestinal bleeding in adults, and the presence or absence of splenomegaly is a useful clinical pointer respectively to the presence or absence of oesophageal varices.

Entities:  

Mesh:

Year:  1989        PMID: 2788073

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  Esophagogastroduodenoscopy in a public referral hospital in Lilongwe, Malawi: spectrum of disease and associated risk factors.

Authors:  Lindsey L Wolf; Rahim Ibrahim; Changchun Miao; Arturo Muyco; Mina C Hosseinipour; Carol Shores
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.282

2.  Profiling lifetime episodes of upper gastrointestinal bleeding among patients from rural Sub-Saharan Africa where schistosoma mansoni is endemic.

Authors:  Christopher Kenneth Opio; Francis Kazibwe; Ponsiano Ocama; Lalitha Rejani; Elena Nikolaevna Belousova; Paul Ajal
Journal:  Pan Afr Med J       Date:  2016-08-03

3.  The diagnostic accuracy of routine clinical findings for detection of esophageal varices in rural sub-Saharan Africa where schistosomiasis is endemic.

Authors:  Christopher K Opio; Lalitha Rejani; Francis Kazibwe; Ponsiano Ocama
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.